Tectonic Therapeutic, Inc. (TECX)
TECX Stock Price Chart
Explore Tectonic Therapeutic, Inc. interactive price chart. Choose custom timeframes to analyze TECX price movements and trends.
TECX Company Profile
Discover essential business fundamentals and corporate details for Tectonic Therapeutic, Inc. (TECX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
51.00
Website
https://tectonictx.comCEO
Alise S. Reicin
Description
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.
TECX Financial Timeline
Browse a chronological timeline of Tectonic Therapeutic, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$1.05.
Earnings released on 7 Aug 2025
EPS came in at -$1.07 falling short of the estimated -$0.98 by -9.18%.
Earnings released on 8 May 2025
EPS came in at -$0.93 surpassing the estimated -$1.10 by +15.45%.
Earnings released on 20 Mar 2025
EPS came in at -$0.84 surpassing the estimated -$1.39 by +39.57%.
Earnings released on 7 Nov 2024
EPS came in at -$1.20 falling short of the estimated -$0.84 by -42.86%.
Earnings released on 14 Aug 2024
EPS came in at -$3.81 falling short of the estimated -$1.96 by -94.39%.
Stock split effective on 21 Jun 2024
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2024
EPS came in at -$1.80 surpassing the estimated -$4.32 by +58.33%.
Earnings released on 14 Mar 2024
EPS came in at -$2.40 surpassing the estimated -$4.04 by +40.59%.
Earnings released on 29 Sept 2023
EPS came in at -$5.81 falling short of the estimated -$4.22 by -37.67%.
Earnings released on 29 Jun 2023
EPS came in at $18.29 surpassing the estimated -$6.49 by +381.78%.
Earnings released on 30 Mar 2023
EPS came in at -$6.80 falling short of the estimated -$6.45 by -5.51%.
Earnings released on 31 Dec 2022
EPS came in at -$6.86 falling short of the estimated -$5.91 by -16.00%.
Earnings released on 29 Sept 2022
EPS came in at -$6.30 surpassing the estimated -$6.60 by +4.59%.
Earnings released on 29 Jun 2022
EPS came in at -$7.70 .
Earnings released on 30 Mar 2022
EPS came in at -$8.19 falling short of the estimated -$6.87 by -19.32%.
Earnings released on 30 Dec 2021
EPS came in at -$7.76 .
Earnings released on 29 Sept 2021
EPS came in at -$8.97 .
Earnings released on 30 Jun 2021
EPS came in at -$0.74 .
Earnings released on 31 Mar 2021
EPS came in at -$7.76 .
Earnings released on 31 Dec 2020
EPS came in at -$8.76 .
Earnings released on 30 Sept 2020
EPS came in at -$12.11 .
TECX Stock Performance
Access detailed TECX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.